# Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy

> **NCT01247558** · — · COMPLETED · sponsor: **Pamlab, L.L.C.** · enrollment: 500 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy (DPN)

## Interventions

- **OTHER:** Metanx® (a medical food)
- **OTHER:** Not treated with Metanx®

## Key facts

- **NCT ID:** NCT01247558
- **Lead sponsor:** Pamlab, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2012-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247558, "Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01247558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*